nodes	percent_of_prediction	percent_of_DWPC	metapath
Perindopril—ABCB1—hematologic cancer	0.175	1	CbGaD
Perindopril—BCHE—Triamcinolone—hematologic cancer	0.0592	0.138	CbGbCtD
Perindopril—BCHE—Irinotecan—hematologic cancer	0.0449	0.105	CbGbCtD
Perindopril—ABCB1—Lenalidomide—hematologic cancer	0.0406	0.0947	CbGbCtD
Perindopril—BCHE—Cisplatin—hematologic cancer	0.0366	0.0853	CbGbCtD
Perindopril—ABCB1—Daunorubicin—hematologic cancer	0.0238	0.0555	CbGbCtD
Perindopril—ABCB1—Alitretinoin—hematologic cancer	0.0233	0.0544	CbGbCtD
Perindopril—ABCB1—Imatinib—hematologic cancer	0.0182	0.0425	CbGbCtD
Perindopril—ABCB1—Nilotinib—hematologic cancer	0.0166	0.0386	CbGbCtD
Perindopril—ABCB1—Vinorelbine—hematologic cancer	0.0164	0.0383	CbGbCtD
Perindopril—ABCB1—Dasatinib—hematologic cancer	0.0146	0.0342	CbGbCtD
Perindopril—ABCB1—Mitoxantrone—hematologic cancer	0.0145	0.0337	CbGbCtD
Perindopril—ABCB1—Betamethasone—hematologic cancer	0.0129	0.0301	CbGbCtD
Perindopril—ABCB1—Gemcitabine—hematologic cancer	0.0128	0.0298	CbGbCtD
Perindopril—ABCB1—Prednisolone—hematologic cancer	0.0127	0.0297	CbGbCtD
Perindopril—ABCB1—Prednisone—hematologic cancer	0.012	0.028	CbGbCtD
Perindopril—ABCB1—Irinotecan—hematologic cancer	0.0114	0.0266	CbGbCtD
Perindopril—ABCB1—Vinblastine—hematologic cancer	0.0101	0.0236	CbGbCtD
Perindopril—ABCB1—Vincristine—hematologic cancer	0.00996	0.0232	CbGbCtD
Perindopril—ABCB1—Cisplatin—hematologic cancer	0.00929	0.0217	CbGbCtD
Perindopril—ABCB1—Etoposide—hematologic cancer	0.00912	0.0213	CbGbCtD
Perindopril—ABCB1—Dexamethasone—hematologic cancer	0.0075	0.0175	CbGbCtD
Perindopril—ABCB1—Doxorubicin—hematologic cancer	0.00622	0.0145	CbGbCtD
Perindopril—ABCB1—Methotrexate—hematologic cancer	0.00603	0.0141	CbGbCtD
Perindopril—ACE—hematopoietic system—hematologic cancer	0.000702	0.0914	CbGeAlD
Perindopril—ACE—gonad—hematologic cancer	0.000533	0.0695	CbGeAlD
Perindopril—BCHE—hematopoietic system—hematologic cancer	0.000518	0.0675	CbGeAlD
Perindopril—ACE—blood—hematologic cancer	0.000465	0.0605	CbGeAlD
Perindopril—ACE—bone marrow—hematologic cancer	0.00045	0.0586	CbGeAlD
Perindopril—ACE—lung—hematologic cancer	0.000407	0.0531	CbGeAlD
Perindopril—SLC15A2—blood—hematologic cancer	0.000405	0.0528	CbGeAlD
Perindopril—ACE—testis—hematologic cancer	0.000384	0.0501	CbGeAlD
Perindopril—SLC15A2—lung—hematologic cancer	0.000355	0.0463	CbGeAlD
Perindopril—BCHE—blood—hematologic cancer	0.000343	0.0447	CbGeAlD
Perindopril—SLC15A2—testis—hematologic cancer	0.000335	0.0437	CbGeAlD
Perindopril—BCHE—bone marrow—hematologic cancer	0.000332	0.0433	CbGeAlD
Perindopril—BCHE—lung—hematologic cancer	0.000301	0.0392	CbGeAlD
Perindopril—BCHE—testis—hematologic cancer	0.000284	0.037	CbGeAlD
Perindopril—ACE—lymph node—hematologic cancer	0.000279	0.0363	CbGeAlD
Perindopril—ABCB1—hematopoietic system—hematologic cancer	0.000247	0.0322	CbGeAlD
Perindopril—SLC15A2—lymph node—hematologic cancer	0.000243	0.0316	CbGeAlD
Perindopril—BCHE—lymph node—hematologic cancer	0.000206	0.0268	CbGeAlD
Perindopril—ABCB1—gonad—hematologic cancer	0.000188	0.0245	CbGeAlD
Perindopril—ABCB1—blood—hematologic cancer	0.000164	0.0213	CbGeAlD
Perindopril—ABCB1—bone marrow—hematologic cancer	0.000158	0.0206	CbGeAlD
Perindopril—ABCB1—lung—hematologic cancer	0.000143	0.0187	CbGeAlD
Perindopril—ABCB1—testis—hematologic cancer	0.000135	0.0176	CbGeAlD
Perindopril—ABCB1—lymph node—hematologic cancer	9.81e-05	0.0128	CbGeAlD
Perindopril—SLC15A1—Transmembrane transport of small molecules—TFRC—hematologic cancer	5.12e-05	0.00094	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—hematologic cancer	5.07e-05	0.00093	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—TUBB2A—hematologic cancer	5.06e-05	0.000928	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SMPD3—hematologic cancer	5.04e-05	0.000925	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—SPHK1—hematologic cancer	5.03e-05	0.000923	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—FOS—hematologic cancer	4.91e-05	0.000901	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—CREB1—hematologic cancer	4.9e-05	0.0009	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—FXYD6—hematologic cancer	4.88e-05	0.000896	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3R1—hematologic cancer	4.86e-05	0.000891	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—CREBBP—hematologic cancer	4.78e-05	0.000876	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PML—hematologic cancer	4.77e-05	0.000875	CbGpPWpGaD
Perindopril—SLC15A2—SLC-mediated transmembrane transport—ALB—hematologic cancer	4.76e-05	0.000873	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—hematologic cancer	4.7e-05	0.000863	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CRABP1—hematologic cancer	4.7e-05	0.000862	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.63e-05	0.00085	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—ALOX5—hematologic cancer	4.58e-05	0.00084	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—MME—hematologic cancer	4.49e-05	0.000824	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3CB—hematologic cancer	4.49e-05	0.000823	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CD80—hematologic cancer	4.47e-05	0.00082	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CMA1—hematologic cancer	4.44e-05	0.000815	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—SUMO1—hematologic cancer	4.44e-05	0.000815	CbGpPWpGaD
Perindopril—SLC15A1—SLC-mediated transmembrane transport—ALB—hematologic cancer	4.42e-05	0.00081	CbGpPWpGaD
Perindopril—BCHE—Metabolism—B3GAT1—hematologic cancer	4.41e-05	0.000808	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ASNS—hematologic cancer	4.41e-05	0.000808	CbGpPWpGaD
Perindopril—BCHE—Metabolism—DCK—hematologic cancer	4.41e-05	0.000808	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TOP2A—hematologic cancer	4.36e-05	0.0008	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—SPHK1—hematologic cancer	4.35e-05	0.000797	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP7—hematologic cancer	4.34e-05	0.000796	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—NCOA3—hematologic cancer	4.31e-05	0.00079	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—CYCS—hematologic cancer	4.3e-05	0.000789	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—PRKCG—hematologic cancer	4.28e-05	0.000786	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HDC—hematologic cancer	4.18e-05	0.000766	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CASP8—hematologic cancer	4.16e-05	0.000762	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EZH2—hematologic cancer	4.14e-05	0.00076	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—CREB1—hematologic cancer	4.14e-05	0.00076	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—BRAF—hematologic cancer	4.09e-05	0.00075	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—S100A10—hematologic cancer	3.98e-05	0.00073	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—SDC1—hematologic cancer	3.89e-05	0.000714	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—RPS14—hematologic cancer	3.89e-05	0.000714	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PTEN—hematologic cancer	3.88e-05	0.000711	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.87e-05	0.000709	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CDA—hematologic cancer	3.82e-05	0.000701	CbGpPWpGaD
Perindopril—ACE—Metabolism of proteins—CCL2—hematologic cancer	3.78e-05	0.000693	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—IL3—hematologic cancer	3.77e-05	0.000692	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC35B2—hematologic cancer	3.7e-05	0.000679	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PC—hematologic cancer	3.68e-05	0.000675	CbGpPWpGaD
Perindopril—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—hematologic cancer	3.6e-05	0.00066	CbGpPWpGaD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ABCB1—hematologic cancer	3.59e-05	0.000658	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GBA—hematologic cancer	3.55e-05	0.000652	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC35B2—hematologic cancer	3.55e-05	0.000652	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IFNG—hematologic cancer	3.53e-05	0.000648	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—JUN—hematologic cancer	3.53e-05	0.000647	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—hematologic cancer	3.51e-05	0.000644	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ATP1B1—hematologic cancer	3.48e-05	0.000638	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—MDM2—hematologic cancer	3.43e-05	0.000628	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—EIF4EBP1—hematologic cancer	3.4e-05	0.000624	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—AR—hematologic cancer	3.39e-05	0.000622	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC26A4—hematologic cancer	3.3e-05	0.000605	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—GRB2—hematologic cancer	3.28e-05	0.000602	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFA—hematologic cancer	3.27e-05	0.000601	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—EP300—hematologic cancer	3.25e-05	0.000597	CbGpPWpGaD
Perindopril—BCHE—Metabolism—MTAP—hematologic cancer	3.25e-05	0.000596	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—CREB1—hematologic cancer	3.17e-05	0.000582	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ABL1—hematologic cancer	3.15e-05	0.000579	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—STAT5A—hematologic cancer	3.15e-05	0.000579	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL1B—hematologic cancer	3.15e-05	0.000578	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—HSPA5—hematologic cancer	3.15e-05	0.000578	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—CASP3—hematologic cancer	3.14e-05	0.000577	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—IL2—hematologic cancer	3.14e-05	0.000576	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—BRAF—hematologic cancer	3.13e-05	0.000575	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—hematologic cancer	3.13e-05	0.000574	CbGpPWpGaD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—VEGFA—hematologic cancer	3.08e-05	0.000565	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—CALR—hematologic cancer	3.05e-05	0.00056	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ATP4A—hematologic cancer	3.02e-05	0.000553	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ANXA2—hematologic cancer	3.02e-05	0.000553	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—SGK1—hematologic cancer	3.02e-05	0.000553	CbGpPWpGaD
Perindopril—BCHE—Metabolism of proteins—FBXW7—hematologic cancer	2.95e-05	0.000541	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF1—hematologic cancer	2.93e-05	0.000538	CbGpPWpGaD
Perindopril—BCHE—Metabolism—FHL2—hematologic cancer	2.9e-05	0.000531	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—hematologic cancer	2.89e-05	0.00053	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PDGFRA—hematologic cancer	2.84e-05	0.000521	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AGRN—hematologic cancer	2.84e-05	0.000521	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—hematologic cancer	2.76e-05	0.000506	CbGpPWpGaD
Perindopril—BCHE—Phospholipid metabolism—PIK3CA—hematologic cancer	2.73e-05	0.000502	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—TUBB2A—hematologic cancer	2.72e-05	0.000498	CbGpPWpGaD
Perindopril—BCHE—Metabolism—IDH2—hematologic cancer	2.69e-05	0.000494	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HMMR—hematologic cancer	2.69e-05	0.000494	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GMPS—hematologic cancer	2.69e-05	0.000493	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—FTCD—hematologic cancer	2.69e-05	0.000493	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PHYH—hematologic cancer	2.69e-05	0.000493	CbGpPWpGaD
Perindopril—ABCB1—Allograft Rejection—VEGFA—hematologic cancer	2.67e-05	0.00049	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—hematologic cancer	2.66e-05	0.000488	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—MDM2—hematologic cancer	2.62e-05	0.000482	CbGpPWpGaD
Perindopril—SLC15A2—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.58e-05	0.000474	CbGpPWpGaD
Perindopril—Rash—Cisplatin—hematologic cancer	2.54e-05	7.61e-05	CcSEcCtD
Perindopril—Dermatitis—Cisplatin—hematologic cancer	2.54e-05	7.6e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—NCOR1—hematologic cancer	2.54e-05	0.000466	CbGpPWpGaD
Perindopril—Erythema—Epirubicin—hematologic cancer	2.54e-05	7.6e-05	CcSEcCtD
Perindopril—Malnutrition—Epirubicin—hematologic cancer	2.54e-05	7.6e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—ARNTL—hematologic cancer	2.53e-05	0.000464	CbGpPWpGaD
Perindopril—Diarrhoea—Etoposide—hematologic cancer	2.53e-05	7.57e-05	CcSEcCtD
Perindopril—Anorexia—Prednisone—hematologic cancer	2.52e-05	7.56e-05	CcSEcCtD
Perindopril—Eye disorder—Doxorubicin—hematologic cancer	2.52e-05	7.55e-05	CcSEcCtD
Perindopril—Ill-defined disorder—Methotrexate—hematologic cancer	2.52e-05	7.53e-05	CcSEcCtD
Perindopril—Tinnitus—Doxorubicin—hematologic cancer	2.51e-05	7.53e-05	CcSEcCtD
Perindopril—Anaemia—Methotrexate—hematologic cancer	2.51e-05	7.5e-05	CcSEcCtD
Perindopril—Feeling abnormal—Dexamethasone—hematologic cancer	2.51e-05	7.5e-05	CcSEcCtD
Perindopril—Feeling abnormal—Betamethasone—hematologic cancer	2.51e-05	7.5e-05	CcSEcCtD
Perindopril—Cardiac disorder—Doxorubicin—hematologic cancer	2.5e-05	7.49e-05	CcSEcCtD
Perindopril—Flushing—Doxorubicin—hematologic cancer	2.5e-05	7.49e-05	CcSEcCtD
Perindopril—Flatulence—Epirubicin—hematologic cancer	2.5e-05	7.49e-05	CcSEcCtD
Perindopril—Tension—Epirubicin—hematologic cancer	2.49e-05	7.45e-05	CcSEcCtD
Perindopril—Gastrointestinal pain—Dexamethasone—hematologic cancer	2.49e-05	7.44e-05	CcSEcCtD
Perindopril—Gastrointestinal pain—Betamethasone—hematologic cancer	2.49e-05	7.44e-05	CcSEcCtD
Perindopril—Dysgeusia—Epirubicin—hematologic cancer	2.48e-05	7.44e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—hematologic cancer	2.48e-05	0.000454	CbGpPWpGaD
Perindopril—Nervousness—Epirubicin—hematologic cancer	2.46e-05	7.38e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—CA9—hematologic cancer	2.46e-05	0.000452	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ACP5—hematologic cancer	2.46e-05	0.000452	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SMPD3—hematologic cancer	2.46e-05	0.000451	CbGpPWpGaD
Perindopril—Back pain—Epirubicin—hematologic cancer	2.45e-05	7.35e-05	CcSEcCtD
Perindopril—ABCB1—Allograft Rejection—TGFB1—hematologic cancer	2.45e-05	0.000449	CbGpPWpGaD
Perindopril—Angiopathy—Doxorubicin—hematologic cancer	2.45e-05	7.33e-05	CcSEcCtD
Perindopril—Malaise—Methotrexate—hematologic cancer	2.44e-05	7.32e-05	CcSEcCtD
Perindopril—Dizziness—Etoposide—hematologic cancer	2.44e-05	7.31e-05	CcSEcCtD
Perindopril—Muscle spasms—Epirubicin—hematologic cancer	2.44e-05	7.3e-05	CcSEcCtD
Perindopril—Vertigo—Methotrexate—hematologic cancer	2.44e-05	7.29e-05	CcSEcCtD
Perindopril—Mediastinal disorder—Doxorubicin—hematologic cancer	2.43e-05	7.28e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—NCOR2—hematologic cancer	2.43e-05	0.000446	CbGpPWpGaD
Perindopril—Leukopenia—Methotrexate—hematologic cancer	2.43e-05	7.27e-05	CcSEcCtD
Perindopril—Chills—Doxorubicin—hematologic cancer	2.42e-05	7.24e-05	CcSEcCtD
Perindopril—SLC15A2—Transmembrane transport of small molecules—ALB—hematologic cancer	2.42e-05	0.000444	CbGpPWpGaD
Perindopril—Urticaria—Betamethasone—hematologic cancer	2.42e-05	7.23e-05	CcSEcCtD
Perindopril—Urticaria—Dexamethasone—hematologic cancer	2.42e-05	7.23e-05	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Prednisone—hematologic cancer	2.41e-05	7.22e-05	CcSEcCtD
Perindopril—Dizziness—Prednisolone—hematologic cancer	2.41e-05	7.21e-05	CcSEcCtD
Perindopril—Arrhythmia—Doxorubicin—hematologic cancer	2.41e-05	7.21e-05	CcSEcCtD
Perindopril—Asthenia—Triamcinolone—hematologic cancer	2.4e-05	7.2e-05	CcSEcCtD
Perindopril—Body temperature increased—Betamethasone—hematologic cancer	2.4e-05	7.2e-05	CcSEcCtD
Perindopril—Body temperature increased—Dexamethasone—hematologic cancer	2.4e-05	7.2e-05	CcSEcCtD
Perindopril—Abdominal pain—Dexamethasone—hematologic cancer	2.4e-05	7.2e-05	CcSEcCtD
Perindopril—Abdominal pain—Betamethasone—hematologic cancer	2.4e-05	7.2e-05	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	2.4e-05	0.00044	CbGpPWpGaD
Perindopril—Nausea—Cisplatin—hematologic cancer	2.4e-05	7.17e-05	CcSEcCtD
Perindopril—Insomnia—Prednisone—hematologic cancer	2.39e-05	7.17e-05	CcSEcCtD
Perindopril—ABCB1—Transmembrane transport of small molecules—ABCC3—hematologic cancer	2.38e-05	0.000437	CbGpPWpGaD
Perindopril—Alopecia—Doxorubicin—hematologic cancer	2.38e-05	7.13e-05	CcSEcCtD
Perindopril—Paraesthesia—Prednisone—hematologic cancer	2.38e-05	7.12e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK14—hematologic cancer	2.37e-05	0.000436	CbGpPWpGaD
Perindopril—Pruritus—Triamcinolone—hematologic cancer	2.37e-05	7.1e-05	CcSEcCtD
Perindopril—Cough—Methotrexate—hematologic cancer	2.37e-05	7.08e-05	CcSEcCtD
Perindopril—Mental disorder—Doxorubicin—hematologic cancer	2.36e-05	7.07e-05	CcSEcCtD
Perindopril—Ill-defined disorder—Epirubicin—hematologic cancer	2.35e-05	7.05e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—hematologic cancer	2.35e-05	0.000431	CbGpPWpGaD
Perindopril—Vomiting—Etoposide—hematologic cancer	2.35e-05	7.03e-05	CcSEcCtD
Perindopril—Erythema—Doxorubicin—hematologic cancer	2.35e-05	7.03e-05	CcSEcCtD
Perindopril—Malnutrition—Doxorubicin—hematologic cancer	2.35e-05	7.03e-05	CcSEcCtD
Perindopril—Anaemia—Epirubicin—hematologic cancer	2.35e-05	7.02e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—hematologic cancer	2.34e-05	0.000429	CbGpPWpGaD
Perindopril—Agitation—Epirubicin—hematologic cancer	2.33e-05	6.98e-05	CcSEcCtD
Perindopril—Dyspepsia—Prednisone—hematologic cancer	2.33e-05	6.98e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—hematologic cancer	2.33e-05	0.000427	CbGpPWpGaD
Perindopril—Rash—Etoposide—hematologic cancer	2.33e-05	6.97e-05	CcSEcCtD
Perindopril—Dermatitis—Etoposide—hematologic cancer	2.33e-05	6.97e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—IDH1—hematologic cancer	2.31e-05	0.000425	CbGpPWpGaD
Perindopril—Headache—Etoposide—hematologic cancer	2.31e-05	6.93e-05	CcSEcCtD
Perindopril—Flatulence—Doxorubicin—hematologic cancer	2.31e-05	6.93e-05	CcSEcCtD
Perindopril—Chest pain—Methotrexate—hematologic cancer	2.31e-05	6.91e-05	CcSEcCtD
Perindopril—Myalgia—Methotrexate—hematologic cancer	2.31e-05	6.91e-05	CcSEcCtD
Perindopril—Arthralgia—Methotrexate—hematologic cancer	2.31e-05	6.91e-05	CcSEcCtD
Perindopril—Tension—Doxorubicin—hematologic cancer	2.3e-05	6.9e-05	CcSEcCtD
Perindopril—Decreased appetite—Prednisone—hematologic cancer	2.3e-05	6.89e-05	CcSEcCtD
Perindopril—Dysgeusia—Doxorubicin—hematologic cancer	2.3e-05	6.88e-05	CcSEcCtD
Perindopril—Rash—Prednisolone—hematologic cancer	2.3e-05	6.88e-05	CcSEcCtD
Perindopril—Dermatitis—Prednisolone—hematologic cancer	2.3e-05	6.87e-05	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	2.29e-05	6.86e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—ABCC3—hematologic cancer	2.29e-05	0.00042	CbGpPWpGaD
Perindopril—BCHE—Metabolism—TXN—hematologic cancer	2.29e-05	0.00042	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTO1—hematologic cancer	2.29e-05	0.00042	CbGpPWpGaD
Perindopril—Malaise—Epirubicin—hematologic cancer	2.29e-05	6.85e-05	CcSEcCtD
Perindopril—ABCB1—Allograft Rejection—TNF—hematologic cancer	2.29e-05	0.00042	CbGpPWpGaD
Perindopril—Fatigue—Prednisone—hematologic cancer	2.28e-05	6.83e-05	CcSEcCtD
Perindopril—Headache—Prednisolone—hematologic cancer	2.28e-05	6.83e-05	CcSEcCtD
Perindopril—Discomfort—Methotrexate—hematologic cancer	2.28e-05	6.83e-05	CcSEcCtD
Perindopril—Nervousness—Doxorubicin—hematologic cancer	2.28e-05	6.83e-05	CcSEcCtD
Perindopril—Vertigo—Epirubicin—hematologic cancer	2.28e-05	6.82e-05	CcSEcCtD
Perindopril—Syncope—Epirubicin—hematologic cancer	2.28e-05	6.81e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BAD—hematologic cancer	2.27e-05	0.000417	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—NFKBIA—hematologic cancer	2.27e-05	0.000417	CbGpPWpGaD
Perindopril—Leukopenia—Epirubicin—hematologic cancer	2.27e-05	6.8e-05	CcSEcCtD
Perindopril—Back pain—Doxorubicin—hematologic cancer	2.27e-05	6.8e-05	CcSEcCtD
Perindopril—Constipation—Prednisone—hematologic cancer	2.26e-05	6.78e-05	CcSEcCtD
Perindopril—Muscle spasms—Doxorubicin—hematologic cancer	2.26e-05	6.76e-05	CcSEcCtD
Perindopril—SLC15A1—Transmembrane transport of small molecules—ALB—hematologic cancer	2.24e-05	0.000412	CbGpPWpGaD
Perindopril—Palpitations—Epirubicin—hematologic cancer	2.24e-05	6.71e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—SPHK1—hematologic cancer	2.24e-05	0.000411	CbGpPWpGaD
Perindopril—Confusional state—Methotrexate—hematologic cancer	2.23e-05	6.68e-05	CcSEcCtD
Perindopril—Loss of consciousness—Epirubicin—hematologic cancer	2.23e-05	6.68e-05	CcSEcCtD
Perindopril—Dizziness—Triamcinolone—hematologic cancer	2.22e-05	6.63e-05	CcSEcCtD
Perindopril—Cough—Epirubicin—hematologic cancer	2.21e-05	6.63e-05	CcSEcCtD
Perindopril—Anaphylactic shock—Methotrexate—hematologic cancer	2.21e-05	6.62e-05	CcSEcCtD
Perindopril—Nausea—Etoposide—hematologic cancer	2.19e-05	6.57e-05	CcSEcCtD
Perindopril—Hypertension—Epirubicin—hematologic cancer	2.19e-05	6.56e-05	CcSEcCtD
Perindopril—Feeling abnormal—Prednisone—hematologic cancer	2.18e-05	6.53e-05	CcSEcCtD
Perindopril—Asthenia—Betamethasone—hematologic cancer	2.18e-05	6.53e-05	CcSEcCtD
Perindopril—Asthenia—Dexamethasone—hematologic cancer	2.18e-05	6.53e-05	CcSEcCtD
Perindopril—ABCB1—Transmembrane transport of small molecules—SLC22A1—hematologic cancer	2.18e-05	0.0004	CbGpPWpGaD
Perindopril—Ill-defined disorder—Doxorubicin—hematologic cancer	2.18e-05	6.52e-05	CcSEcCtD
Perindopril—Nervous system disorder—Methotrexate—hematologic cancer	2.17e-05	6.5e-05	CcSEcCtD
Perindopril—Anaemia—Doxorubicin—hematologic cancer	2.17e-05	6.5e-05	CcSEcCtD
Perindopril—Thrombocytopenia—Methotrexate—hematologic cancer	2.17e-05	6.49e-05	CcSEcCtD
Perindopril—Gastrointestinal pain—Prednisone—hematologic cancer	2.16e-05	6.48e-05	CcSEcCtD
Perindopril—Nausea—Prednisolone—hematologic cancer	2.16e-05	6.48e-05	CcSEcCtD
Perindopril—Chest pain—Epirubicin—hematologic cancer	2.16e-05	6.47e-05	CcSEcCtD
Perindopril—Arthralgia—Epirubicin—hematologic cancer	2.16e-05	6.47e-05	CcSEcCtD
Perindopril—Myalgia—Epirubicin—hematologic cancer	2.16e-05	6.47e-05	CcSEcCtD
Perindopril—Agitation—Doxorubicin—hematologic cancer	2.16e-05	6.46e-05	CcSEcCtD
Perindopril—Anxiety—Epirubicin—hematologic cancer	2.15e-05	6.44e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—UGT1A1—hematologic cancer	2.15e-05	0.000395	CbGpPWpGaD
Perindopril—Pruritus—Dexamethasone—hematologic cancer	2.15e-05	6.44e-05	CcSEcCtD
Perindopril—Pruritus—Betamethasone—hematologic cancer	2.15e-05	6.44e-05	CcSEcCtD
Perindopril—ABCB1—Metabolism—DCK—hematologic cancer	2.15e-05	0.000394	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—B3GAT1—hematologic cancer	2.15e-05	0.000394	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ASNS—hematologic cancer	2.15e-05	0.000394	CbGpPWpGaD
Perindopril—Skin disorder—Methotrexate—hematologic cancer	2.15e-05	6.43e-05	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	2.15e-05	6.42e-05	CcSEcCtD
Perindopril—Hyperhidrosis—Methotrexate—hematologic cancer	2.14e-05	6.4e-05	CcSEcCtD
Perindopril—Discomfort—Epirubicin—hematologic cancer	2.13e-05	6.39e-05	CcSEcCtD
Perindopril—Vomiting—Triamcinolone—hematologic cancer	2.13e-05	6.38e-05	CcSEcCtD
Perindopril—Malaise—Doxorubicin—hematologic cancer	2.12e-05	6.34e-05	CcSEcCtD
Perindopril—Rash—Triamcinolone—hematologic cancer	2.11e-05	6.32e-05	CcSEcCtD
Perindopril—Dry mouth—Epirubicin—hematologic cancer	2.11e-05	6.32e-05	CcSEcCtD
Perindopril—Dermatitis—Triamcinolone—hematologic cancer	2.11e-05	6.32e-05	CcSEcCtD
Perindopril—Vertigo—Doxorubicin—hematologic cancer	2.11e-05	6.31e-05	CcSEcCtD
Perindopril—Anorexia—Methotrexate—hematologic cancer	2.11e-05	6.31e-05	CcSEcCtD
Perindopril—Syncope—Doxorubicin—hematologic cancer	2.11e-05	6.3e-05	CcSEcCtD
Perindopril—Urticaria—Prednisone—hematologic cancer	2.1e-05	6.3e-05	CcSEcCtD
Perindopril—Leukopenia—Doxorubicin—hematologic cancer	2.1e-05	6.29e-05	CcSEcCtD
Perindopril—Headache—Triamcinolone—hematologic cancer	2.1e-05	6.28e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CREB1—hematologic cancer	2.1e-05	0.000385	CbGpPWpGaD
Perindopril—BCHE—Metabolism—SLC22A1—hematologic cancer	2.09e-05	0.000384	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CRABP1—hematologic cancer	2.09e-05	0.000384	CbGpPWpGaD
Perindopril—Body temperature increased—Prednisone—hematologic cancer	2.09e-05	6.27e-05	CcSEcCtD
Perindopril—Abdominal pain—Prednisone—hematologic cancer	2.09e-05	6.27e-05	CcSEcCtD
Perindopril—Confusional state—Epirubicin—hematologic cancer	2.09e-05	6.25e-05	CcSEcCtD
Perindopril—Diarrhoea—Betamethasone—hematologic cancer	2.08e-05	6.23e-05	CcSEcCtD
Perindopril—Diarrhoea—Dexamethasone—hematologic cancer	2.08e-05	6.23e-05	CcSEcCtD
Perindopril—Palpitations—Doxorubicin—hematologic cancer	2.07e-05	6.21e-05	CcSEcCtD
Perindopril—Oedema—Epirubicin—hematologic cancer	2.07e-05	6.2e-05	CcSEcCtD
Perindopril—Anaphylactic shock—Epirubicin—hematologic cancer	2.07e-05	6.2e-05	CcSEcCtD
Perindopril—Hypotension—Methotrexate—hematologic cancer	2.07e-05	6.19e-05	CcSEcCtD
Perindopril—Loss of consciousness—Doxorubicin—hematologic cancer	2.06e-05	6.18e-05	CcSEcCtD
Perindopril—ABCB1—Transmembrane transport of small molecules—NUP98—hematologic cancer	2.06e-05	0.000378	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—hematologic cancer	2.05e-05	0.000376	CbGpPWpGaD
Perindopril—Cough—Doxorubicin—hematologic cancer	2.05e-05	6.13e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—hematologic cancer	2.04e-05	0.000375	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ALOX5—hematologic cancer	2.04e-05	0.000374	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HDC—hematologic cancer	2.04e-05	0.000374	CbGpPWpGaD
Perindopril—Shock—Epirubicin—hematologic cancer	2.04e-05	6.1e-05	CcSEcCtD
Perindopril—Nervous system disorder—Epirubicin—hematologic cancer	2.03e-05	6.08e-05	CcSEcCtD
Perindopril—Thrombocytopenia—Epirubicin—hematologic cancer	2.03e-05	6.07e-05	CcSEcCtD
Perindopril—Hypertension—Doxorubicin—hematologic cancer	2.03e-05	6.07e-05	CcSEcCtD
Perindopril—Tachycardia—Epirubicin—hematologic cancer	2.02e-05	6.05e-05	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Methotrexate—hematologic cancer	2.02e-05	6.04e-05	CcSEcCtD
Perindopril—Skin disorder—Epirubicin—hematologic cancer	2.01e-05	6.02e-05	CcSEcCtD
Perindopril—Dizziness—Betamethasone—hematologic cancer	2.01e-05	6.02e-05	CcSEcCtD
Perindopril—Dizziness—Dexamethasone—hematologic cancer	2.01e-05	6.02e-05	CcSEcCtD
Perindopril—Hyperhidrosis—Epirubicin—hematologic cancer	2e-05	5.99e-05	CcSEcCtD
Perindopril—Insomnia—Methotrexate—hematologic cancer	2e-05	5.99e-05	CcSEcCtD
Perindopril—Arthralgia—Doxorubicin—hematologic cancer	2e-05	5.98e-05	CcSEcCtD
Perindopril—Chest pain—Doxorubicin—hematologic cancer	2e-05	5.98e-05	CcSEcCtD
Perindopril—Myalgia—Doxorubicin—hematologic cancer	2e-05	5.98e-05	CcSEcCtD
Perindopril—ABCB1—Transmembrane transport of small molecules—ADCY7—hematologic cancer	2e-05	0.000367	CbGpPWpGaD
Perindopril—Anxiety—Doxorubicin—hematologic cancer	1.99e-05	5.96e-05	CcSEcCtD
Perindopril—Nausea—Triamcinolone—hematologic cancer	1.99e-05	5.96e-05	CcSEcCtD
Perindopril—Paraesthesia—Methotrexate—hematologic cancer	1.99e-05	5.95e-05	CcSEcCtD
Perindopril—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	1.98e-05	5.94e-05	CcSEcCtD
Perindopril—ABCB1—Transmembrane transport of small molecules—NUP214—hematologic cancer	1.98e-05	0.000364	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NUP98—hematologic cancer	1.98e-05	0.000362	CbGpPWpGaD
Perindopril—Discomfort—Doxorubicin—hematologic cancer	1.97e-05	5.91e-05	CcSEcCtD
Perindopril—Anorexia—Epirubicin—hematologic cancer	1.97e-05	5.91e-05	CcSEcCtD
Perindopril—Dyspnoea—Methotrexate—hematologic cancer	1.97e-05	5.91e-05	CcSEcCtD
Perindopril—Somnolence—Methotrexate—hematologic cancer	1.97e-05	5.89e-05	CcSEcCtD
Perindopril—ABCB1—HIF-1-alpha transcription factor network—AKT1—hematologic cancer	1.97e-05	0.000361	CbGpPWpGaD
Perindopril—Dry mouth—Doxorubicin—hematologic cancer	1.95e-05	5.85e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAP2K1—hematologic cancer	1.95e-05	0.000357	CbGpPWpGaD
Perindopril—Dyspepsia—Methotrexate—hematologic cancer	1.95e-05	5.83e-05	CcSEcCtD
Perindopril—ABCB1—Transmembrane transport of small molecules—ABCG2—hematologic cancer	1.94e-05	0.000357	CbGpPWpGaD
Perindopril—Hypotension—Epirubicin—hematologic cancer	1.93e-05	5.79e-05	CcSEcCtD
Perindopril—Vomiting—Dexamethasone—hematologic cancer	1.93e-05	5.79e-05	CcSEcCtD
Perindopril—Vomiting—Betamethasone—hematologic cancer	1.93e-05	5.79e-05	CcSEcCtD
Perindopril—Confusional state—Doxorubicin—hematologic cancer	1.93e-05	5.78e-05	CcSEcCtD
Perindopril—Decreased appetite—Methotrexate—hematologic cancer	1.92e-05	5.76e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—ADCY7—hematologic cancer	1.92e-05	0.000352	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NCOA3—hematologic cancer	1.92e-05	0.000352	CbGpPWpGaD
Perindopril—Rash—Dexamethasone—hematologic cancer	1.92e-05	5.74e-05	CcSEcCtD
Perindopril—Rash—Betamethasone—hematologic cancer	1.92e-05	5.74e-05	CcSEcCtD
Perindopril—Oedema—Doxorubicin—hematologic cancer	1.92e-05	5.74e-05	CcSEcCtD
Perindopril—Anaphylactic shock—Doxorubicin—hematologic cancer	1.92e-05	5.74e-05	CcSEcCtD
Perindopril—Dermatitis—Betamethasone—hematologic cancer	1.92e-05	5.73e-05	CcSEcCtD
Perindopril—Dermatitis—Dexamethasone—hematologic cancer	1.92e-05	5.73e-05	CcSEcCtD
Perindopril—Gastrointestinal disorder—Methotrexate—hematologic cancer	1.91e-05	5.72e-05	CcSEcCtD
Perindopril—Fatigue—Methotrexate—hematologic cancer	1.91e-05	5.71e-05	CcSEcCtD
Perindopril—Headache—Betamethasone—hematologic cancer	1.9e-05	5.7e-05	CcSEcCtD
Perindopril—Headache—Dexamethasone—hematologic cancer	1.9e-05	5.7e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—NUP214—hematologic cancer	1.9e-05	0.000349	CbGpPWpGaD
Perindopril—Asthenia—Prednisone—hematologic cancer	1.9e-05	5.69e-05	CcSEcCtD
Perindopril—Pain—Methotrexate—hematologic cancer	1.89e-05	5.66e-05	CcSEcCtD
Perindopril—Musculoskeletal discomfort—Epirubicin—hematologic cancer	1.89e-05	5.65e-05	CcSEcCtD
Perindopril—Shock—Doxorubicin—hematologic cancer	1.88e-05	5.64e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—hematologic cancer	1.88e-05	0.000346	CbGpPWpGaD
Perindopril—BCHE—Transmission across Chemical Synapses—HRAS—hematologic cancer	1.88e-05	0.000345	CbGpPWpGaD
Perindopril—Nervous system disorder—Doxorubicin—hematologic cancer	1.88e-05	5.63e-05	CcSEcCtD
Perindopril—Thrombocytopenia—Doxorubicin—hematologic cancer	1.88e-05	5.62e-05	CcSEcCtD
Perindopril—Pruritus—Prednisone—hematologic cancer	1.87e-05	5.61e-05	CcSEcCtD
Perindopril—Insomnia—Epirubicin—hematologic cancer	1.87e-05	5.61e-05	CcSEcCtD
Perindopril—Tachycardia—Doxorubicin—hematologic cancer	1.87e-05	5.6e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—MTR—hematologic cancer	1.87e-05	0.000342	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ABCG2—hematologic cancer	1.87e-05	0.000342	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CDA—hematologic cancer	1.86e-05	0.000342	CbGpPWpGaD
Perindopril—Skin disorder—Doxorubicin—hematologic cancer	1.86e-05	5.57e-05	CcSEcCtD
Perindopril—Paraesthesia—Epirubicin—hematologic cancer	1.86e-05	5.57e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—hematologic cancer	1.85e-05	0.00034	CbGpPWpGaD
Perindopril—Hyperhidrosis—Doxorubicin—hematologic cancer	1.85e-05	5.55e-05	CcSEcCtD
Perindopril—Dyspnoea—Epirubicin—hematologic cancer	1.85e-05	5.53e-05	CcSEcCtD
Perindopril—Somnolence—Epirubicin—hematologic cancer	1.84e-05	5.51e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—ENO2—hematologic cancer	1.83e-05	0.000336	CbGpPWpGaD
Perindopril—Anorexia—Doxorubicin—hematologic cancer	1.83e-05	5.47e-05	CcSEcCtD
Perindopril—Feeling abnormal—Methotrexate—hematologic cancer	1.82e-05	5.46e-05	CcSEcCtD
Perindopril—Dyspepsia—Epirubicin—hematologic cancer	1.82e-05	5.46e-05	CcSEcCtD
Perindopril—Diarrhoea—Prednisone—hematologic cancer	1.81e-05	5.42e-05	CcSEcCtD
Perindopril—Gastrointestinal pain—Methotrexate—hematologic cancer	1.81e-05	5.42e-05	CcSEcCtD
Perindopril—Nausea—Betamethasone—hematologic cancer	1.81e-05	5.41e-05	CcSEcCtD
Perindopril—Nausea—Dexamethasone—hematologic cancer	1.81e-05	5.41e-05	CcSEcCtD
Perindopril—Decreased appetite—Epirubicin—hematologic cancer	1.8e-05	5.39e-05	CcSEcCtD
Perindopril—ABCB1—Metabolism—PC—hematologic cancer	1.79e-05	0.000329	CbGpPWpGaD
Perindopril—Hypotension—Doxorubicin—hematologic cancer	1.79e-05	5.36e-05	CcSEcCtD
Perindopril—Gastrointestinal disorder—Epirubicin—hematologic cancer	1.79e-05	5.35e-05	CcSEcCtD
Perindopril—Fatigue—Epirubicin—hematologic cancer	1.79e-05	5.34e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—GSTT1—hematologic cancer	1.77e-05	0.000326	CbGpPWpGaD
Perindopril—Constipation—Epirubicin—hematologic cancer	1.77e-05	5.3e-05	CcSEcCtD
Perindopril—Pain—Epirubicin—hematologic cancer	1.77e-05	5.3e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—hematologic cancer	1.76e-05	0.000323	CbGpPWpGaD
Perindopril—Urticaria—Methotrexate—hematologic cancer	1.76e-05	5.26e-05	CcSEcCtD
Perindopril—Dizziness—Prednisone—hematologic cancer	1.75e-05	5.24e-05	CcSEcCtD
Perindopril—Abdominal pain—Methotrexate—hematologic cancer	1.75e-05	5.24e-05	CcSEcCtD
Perindopril—Body temperature increased—Methotrexate—hematologic cancer	1.75e-05	5.24e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—CREBBP—hematologic cancer	1.75e-05	0.000321	CbGpPWpGaD
Perindopril—Musculoskeletal discomfort—Doxorubicin—hematologic cancer	1.75e-05	5.23e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—SDC1—hematologic cancer	1.73e-05	0.000318	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—hematologic cancer	1.73e-05	0.000318	CbGpPWpGaD
Perindopril—Insomnia—Doxorubicin—hematologic cancer	1.73e-05	5.19e-05	CcSEcCtD
Perindopril—ABCB1—Metabolism—SLC35B2—hematologic cancer	1.73e-05	0.000318	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GBA—hematologic cancer	1.73e-05	0.000318	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—TFRC—hematologic cancer	1.73e-05	0.000318	CbGpPWpGaD
Perindopril—Paraesthesia—Doxorubicin—hematologic cancer	1.72e-05	5.15e-05	CcSEcCtD
Perindopril—Dyspnoea—Doxorubicin—hematologic cancer	1.71e-05	5.11e-05	CcSEcCtD
Perindopril—Feeling abnormal—Epirubicin—hematologic cancer	1.71e-05	5.11e-05	CcSEcCtD
Perindopril—Somnolence—Doxorubicin—hematologic cancer	1.7e-05	5.1e-05	CcSEcCtD
Perindopril—Gastrointestinal pain—Epirubicin—hematologic cancer	1.69e-05	5.07e-05	CcSEcCtD
Perindopril—Dyspepsia—Doxorubicin—hematologic cancer	1.69e-05	5.05e-05	CcSEcCtD
Perindopril—Vomiting—Prednisone—hematologic cancer	1.68e-05	5.04e-05	CcSEcCtD
Perindopril—Rash—Prednisone—hematologic cancer	1.67e-05	5e-05	CcSEcCtD
Perindopril—Dermatitis—Prednisone—hematologic cancer	1.67e-05	4.99e-05	CcSEcCtD
Perindopril—Decreased appetite—Doxorubicin—hematologic cancer	1.67e-05	4.99e-05	CcSEcCtD
Perindopril—Headache—Prednisone—hematologic cancer	1.66e-05	4.97e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—hematologic cancer	1.66e-05	0.000304	CbGpPWpGaD
Perindopril—Gastrointestinal disorder—Doxorubicin—hematologic cancer	1.65e-05	4.95e-05	CcSEcCtD
Perindopril—Fatigue—Doxorubicin—hematologic cancer	1.65e-05	4.95e-05	CcSEcCtD
Perindopril—Urticaria—Epirubicin—hematologic cancer	1.64e-05	4.93e-05	CcSEcCtD
Perindopril—Pain—Doxorubicin—hematologic cancer	1.64e-05	4.91e-05	CcSEcCtD
Perindopril—Constipation—Doxorubicin—hematologic cancer	1.64e-05	4.91e-05	CcSEcCtD
Perindopril—Abdominal pain—Epirubicin—hematologic cancer	1.64e-05	4.9e-05	CcSEcCtD
Perindopril—Body temperature increased—Epirubicin—hematologic cancer	1.64e-05	4.9e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—ALB—hematologic cancer	1.64e-05	0.0003	CbGpPWpGaD
Perindopril—Asthenia—Methotrexate—hematologic cancer	1.59e-05	4.75e-05	CcSEcCtD
Perindopril—ABCB1—Metabolism—MTAP—hematologic cancer	1.58e-05	0.000291	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—hematologic cancer	1.58e-05	0.000291	CbGpPWpGaD
Perindopril—Feeling abnormal—Doxorubicin—hematologic cancer	1.58e-05	4.73e-05	CcSEcCtD
Perindopril—Nausea—Prednisone—hematologic cancer	1.57e-05	4.71e-05	CcSEcCtD
Perindopril—Gastrointestinal pain—Doxorubicin—hematologic cancer	1.57e-05	4.69e-05	CcSEcCtD
Perindopril—Pruritus—Methotrexate—hematologic cancer	1.57e-05	4.69e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3R1—hematologic cancer	1.56e-05	0.000287	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—hematologic cancer	1.55e-05	0.000285	CbGpPWpGaD
Perindopril—Urticaria—Doxorubicin—hematologic cancer	1.52e-05	4.56e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of proteins—CCL2—hematologic cancer	1.52e-05	0.000278	CbGpPWpGaD
Perindopril—Abdominal pain—Doxorubicin—hematologic cancer	1.51e-05	4.53e-05	CcSEcCtD
Perindopril—Body temperature increased—Doxorubicin—hematologic cancer	1.51e-05	4.53e-05	CcSEcCtD
Perindopril—Diarrhoea—Methotrexate—hematologic cancer	1.51e-05	4.53e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—hematologic cancer	1.51e-05	0.000277	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—hematologic cancer	1.51e-05	0.000277	CbGpPWpGaD
Perindopril—Asthenia—Epirubicin—hematologic cancer	1.49e-05	4.45e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—NQO1—hematologic cancer	1.47e-05	0.000271	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CD44—hematologic cancer	1.47e-05	0.000271	CbGpPWpGaD
Perindopril—Pruritus—Epirubicin—hematologic cancer	1.46e-05	4.39e-05	CcSEcCtD
Perindopril—Dizziness—Methotrexate—hematologic cancer	1.46e-05	4.38e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—hematologic cancer	1.46e-05	0.000268	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—hematologic cancer	1.46e-05	0.000267	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—CYCS—hematologic cancer	1.45e-05	0.000267	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—hematologic cancer	1.44e-05	0.000265	CbGpPWpGaD
Perindopril—BCHE—Neuronal System—HRAS—hematologic cancer	1.44e-05	0.000264	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—hematologic cancer	1.43e-05	0.000262	CbGpPWpGaD
Perindopril—Diarrhoea—Epirubicin—hematologic cancer	1.42e-05	4.24e-05	CcSEcCtD
Perindopril—ABCB1—Metabolism—FHL2—hematologic cancer	1.41e-05	0.000259	CbGpPWpGaD
Perindopril—Vomiting—Methotrexate—hematologic cancer	1.41e-05	4.21e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—CYCS—hematologic cancer	1.4e-05	0.000256	CbGpPWpGaD
Perindopril—Rash—Methotrexate—hematologic cancer	1.4e-05	4.18e-05	CcSEcCtD
Perindopril—Dermatitis—Methotrexate—hematologic cancer	1.39e-05	4.17e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—hematologic cancer	1.39e-05	0.000255	CbGpPWpGaD
Perindopril—BCHE—Metabolism—HSP90AA1—hematologic cancer	1.39e-05	0.000254	CbGpPWpGaD
Perindopril—Headache—Methotrexate—hematologic cancer	1.39e-05	4.15e-05	CcSEcCtD
Perindopril—ABCB1—Metabolism—AGRN—hematologic cancer	1.39e-05	0.000254	CbGpPWpGaD
Perindopril—Asthenia—Doxorubicin—hematologic cancer	1.37e-05	4.12e-05	CcSEcCtD
Perindopril—Dizziness—Epirubicin—hematologic cancer	1.37e-05	4.1e-05	CcSEcCtD
Perindopril—Pruritus—Doxorubicin—hematologic cancer	1.36e-05	4.06e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—hematologic cancer	1.35e-05	0.000248	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—hematologic cancer	1.32e-05	0.000242	CbGpPWpGaD
Perindopril—Vomiting—Epirubicin—hematologic cancer	1.32e-05	3.94e-05	CcSEcCtD
Perindopril—Nausea—Methotrexate—hematologic cancer	1.31e-05	3.93e-05	CcSEcCtD
Perindopril—ABCB1—Metabolism—IDH2—hematologic cancer	1.31e-05	0.000241	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HMMR—hematologic cancer	1.31e-05	0.000241	CbGpPWpGaD
Perindopril—Diarrhoea—Doxorubicin—hematologic cancer	1.31e-05	3.92e-05	CcSEcCtD
Perindopril—Rash—Epirubicin—hematologic cancer	1.31e-05	3.91e-05	CcSEcCtD
Perindopril—Dermatitis—Epirubicin—hematologic cancer	1.3e-05	3.91e-05	CcSEcCtD
Perindopril—Headache—Epirubicin—hematologic cancer	1.3e-05	3.88e-05	CcSEcCtD
Perindopril—Dizziness—Doxorubicin—hematologic cancer	1.27e-05	3.79e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PTEN—hematologic cancer	1.25e-05	0.000229	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—hematologic cancer	1.25e-05	0.000229	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ARNTL—hematologic cancer	1.23e-05	0.000227	CbGpPWpGaD
Perindopril—BCHE—Metabolism—GSTP1—hematologic cancer	1.23e-05	0.000226	CbGpPWpGaD
Perindopril—Nausea—Epirubicin—hematologic cancer	1.23e-05	3.68e-05	CcSEcCtD
Perindopril—Vomiting—Doxorubicin—hematologic cancer	1.22e-05	3.65e-05	CcSEcCtD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—hematologic cancer	1.21e-05	0.000222	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—hematologic cancer	1.21e-05	0.000222	CbGpPWpGaD
Perindopril—Rash—Doxorubicin—hematologic cancer	1.21e-05	3.62e-05	CcSEcCtD
Perindopril—Dermatitis—Doxorubicin—hematologic cancer	1.21e-05	3.61e-05	CcSEcCtD
Perindopril—ABCB1—Metabolism—CA9—hematologic cancer	1.2e-05	0.00022	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ACP5—hematologic cancer	1.2e-05	0.00022	CbGpPWpGaD
Perindopril—Headache—Doxorubicin—hematologic cancer	1.2e-05	3.59e-05	CcSEcCtD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—EP300—hematologic cancer	1.19e-05	0.000218	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NCOR2—hematologic cancer	1.19e-05	0.000217	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ABCB1—hematologic cancer	1.16e-05	0.000214	CbGpPWpGaD
Perindopril—Nausea—Doxorubicin—hematologic cancer	1.14e-05	3.41e-05	CcSEcCtD
Perindopril—BCHE—Metabolism—GSTM1—hematologic cancer	1.13e-05	0.000207	CbGpPWpGaD
Perindopril—BCHE—Metabolism—NCOR1—hematologic cancer	1.13e-05	0.000207	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—IDH1—hematologic cancer	1.13e-05	0.000207	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—hematologic cancer	1.13e-05	0.000207	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—hematologic cancer	1.12e-05	0.000205	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTO1—hematologic cancer	1.12e-05	0.000205	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ABCC3—hematologic cancer	1.12e-05	0.000205	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—TXN—hematologic cancer	1.12e-05	0.000205	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SPHK1—hematologic cancer	1.09e-05	0.0002	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—UGT1A1—hematologic cancer	1.05e-05	0.000193	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—hematologic cancer	1.03e-05	0.000189	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CRABP1—hematologic cancer	1.02e-05	0.000187	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SLC22A1—hematologic cancer	1.02e-05	0.000187	CbGpPWpGaD
Perindopril—BCHE—Metabolism—MTHFR—hematologic cancer	9.99e-06	0.000183	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ALOX5—hematologic cancer	9.95e-06	0.000183	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—hematologic cancer	9.95e-06	0.000183	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NUP98—hematologic cancer	9.64e-06	0.000177	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ADCY7—hematologic cancer	9.36e-06	0.000172	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NCOA3—hematologic cancer	9.36e-06	0.000172	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NUP214—hematologic cancer	9.29e-06	0.00017	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ABCG2—hematologic cancer	9.1e-06	0.000167	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—MTR—hematologic cancer	9.1e-06	0.000167	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ENO2—hematologic cancer	8.93e-06	0.000164	CbGpPWpGaD
Perindopril—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—hematologic cancer	8.8e-06	0.000162	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTT1—hematologic cancer	8.66e-06	0.000159	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—SDC1—hematologic cancer	8.46e-06	0.000155	CbGpPWpGaD
Perindopril—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—hematologic cancer	8.4e-06	0.000154	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CG—hematologic cancer	8.39e-06	0.000154	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—CREBBP—hematologic cancer	8.11e-06	0.000149	CbGpPWpGaD
Perindopril—BCHE—Metabolism—CREBBP—hematologic cancer	7.78e-06	0.000143	CbGpPWpGaD
Perindopril—ABCB1—Transmembrane transport of small molecules—ALB—hematologic cancer	7.59e-06	0.000139	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CD—hematologic cancer	7.38e-06	0.000135	CbGpPWpGaD
Perindopril—BCHE—Metabolism—ALB—hematologic cancer	7.28e-06	0.000134	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NQO1—hematologic cancer	7.2e-06	0.000132	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CD44—hematologic cancer	7.2e-06	0.000132	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3R1—hematologic cancer	6.97e-06	0.000128	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CYCS—hematologic cancer	6.81e-06	0.000125	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—HSP90AA1—hematologic cancer	6.77e-06	0.000124	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CB—hematologic cancer	6.43e-06	0.000118	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTP1—hematologic cancer	6e-06	0.00011	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PTEN—hematologic cancer	5.56e-06	0.000102	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—GSTM1—hematologic cancer	5.51e-06	0.000101	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—NCOR1—hematologic cancer	5.51e-06	0.000101	CbGpPWpGaD
Perindopril—BCHE—Metabolism—EP300—hematologic cancer	5.3e-06	9.72e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—MTHFR—hematologic cancer	4.87e-06	8.94e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CG—hematologic cancer	4.1e-06	7.51e-05	CbGpPWpGaD
Perindopril—BCHE—Metabolism—PIK3CA—hematologic cancer	3.92e-06	7.19e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—CREBBP—hematologic cancer	3.8e-06	6.97e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CD—hematologic cancer	3.6e-06	6.6e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—ALB—hematologic cancer	3.55e-06	6.52e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3R1—hematologic cancer	3.4e-06	6.24e-05	CbGpPWpGaD
Perindopril—BCHE—Metabolism—AKT1—hematologic cancer	3.2e-06	5.88e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CB—hematologic cancer	3.14e-06	5.76e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PTEN—hematologic cancer	2.71e-06	4.97e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—EP300—hematologic cancer	2.59e-06	4.74e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—PIK3CA—hematologic cancer	1.91e-06	3.51e-05	CbGpPWpGaD
Perindopril—ABCB1—Metabolism—AKT1—hematologic cancer	1.56e-06	2.87e-05	CbGpPWpGaD
